Delivery Order SPE2DB25D3005-SPE2DB25FQEFP

Award Date 4/15/25
Potential Completion Date 5/6/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,851.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a delivery order to supply the medication Esbriet 801 mg tablet in quantities of 90s. The contract is a firm fixed-price, non-set-aside award with a completion date of May 20, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.95, is for the delivery of Esbriet 801 mg tablets in quantities of 90 per order. This is a Firm Fixed Price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $13,246.00 for the supply of Esbriet 267 mg tablets. The contract, which has an ultimate completion date of October 16, 2024, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency responsible for providing medical supplies to the U.S. military. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a $3,311.50 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of Esbriet 801 mg tablets and has a period of performance through July 29, 2024. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to supply Esbriet 801 mg tablets to the government. The Delivery Order, valued at $3,311.50, has a firm fixed price and an ultimate completion date of July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $3,311.50 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), which has a $999,999,999 ceiling value and runs through November 2026. The contract delivers Esbriet 801 mg tablets for use in federal healthcare programs. The award has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,851.90 firm fixed-price delivery order is for the supply of 4,568,160,448 tablets of the medication Esbriet 267 mg. The contract has a performance period through May 28, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,851.90 firm fixed-price delivery order contract is for the supply of Esbriet 267 mg capsules. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is a Delivery Order valued at $3,425.95 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The award covers the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that holds an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distribution company. The contract, valued at up to $3,311.50, is for the delivery of the prescription medication Esbriet (pirfenidone) 801 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00...
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQEFP
    Delivery Order

This federal contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Esbriet 801 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of May 6, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

This contract award is not designated as a set-aside and is open to full and open competition.

Generated 7/15/25, 3:40 PM